Correlation Between Puma Biotechnology and Sana Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Sana Biotechnology, you can compare the effects of market volatilities on Puma Biotechnology and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Sana Biotechnology.

Diversification Opportunities for Puma Biotechnology and Sana Biotechnology

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Puma and Sana is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Sana Biotechnology

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 0.82 times more return on investment than Sana Biotechnology. However, Puma Biotechnology is 1.23 times less risky than Sana Biotechnology. It trades about 0.02 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.13 per unit of risk. If you would invest  297.00  in Puma Biotechnology on September 14, 2024 and sell it today you would lose (5.00) from holding Puma Biotechnology or give up 1.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Puma Biotechnology  vs.  Sana Biotechnology

 Performance 
       Timeline  
Puma Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Puma Biotechnology and Sana Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Puma Biotechnology and Sana Biotechnology

The main advantage of trading using opposite Puma Biotechnology and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.
The idea behind Puma Biotechnology and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities